A SIMULATION STUDY TO PROVIDE GUIDANCE FOR INDIVIDUALS TRANSITIONING FROM EMICIZUMAB TO VALOCTOCOGENE ROXAPARVOVEC W Kuwabara; D Osmond; J Henshaw; S Agarwal; V Newman; C Hermans; W Miesbach; S Pipe; RS Jr; F Peyvandi;

EFFICACY AND SAFETY OF VALOCTOCOGENE ROXAPARVOVEC 4 YEARS AFTER GENE TRANSFER IN GENER8-1 MC Ozelo; AD Leavitt; J Mahlangu; G Kenet; SW Pipe; S Chou; R Klamroth; F Peyvandi; T Robinson; GT Group;

BLEEDING RATE, FVIII UTILIZATION, CORTICOSTEROID USE, QUALITY OF LIFE AND SAFETY 4-YEARS AFTER GENE TRANSFER WITH VALOCTOCOGENE ROXAPARVOVEC IN A BRAZILIAN COHORT: RESULTS FROM GENER8-1 MC Ozelo; GGY Hayakawa; ANL Prezotti; MH Cerqueira; PR Villaça; C Lorenzatto; T Robinson;